Rbx1, a Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase

Takumi Kamura(Howard Hughes Medical Institute), Deanna M. Koepp(Howard Hughes Medical Institute), Michael N. Conrad(Oklahoma Medical Research Foundation), Dorota Skowyra, Rodney J. Moreland(Oklahoma Medical Research Foundation), Othon Iliopoulos(Brigham and Women's Hospital), W S Lane(Harvard University Press), William G. Kaelin(Howard Hughes Medical Institute), Stephen J. Elledge(Howard Hughes Medical Institute), Ronald Conaway(Oklahoma Medical Research Foundation), J. Wade Harper, Joan Conaway(Howard Hughes Medical Institute)
Science
April 23, 1999
Cited by 787

Abstract

The von Hippel–Lindau (VHL) tumor suppressor gene is mutated in most human kidney cancers. The VHL protein is part of a complex that includes Elongin B, Elongin C, and Cullin-2, proteins associated with transcriptional elongation and ubiquitination. Here it is shown that the endogenous VHL complex in rat liver also includes Rbx1, an evolutionarily conserved protein that contains a RING-H2 fingerlike motif and that interacts with Cullins. The yeast homolog of Rbx1 is a subunit and potent activator of the Cdc53-containing SCF Cdc4 ubiquitin ligase required for ubiquitination of the cyclin-dependent kinase inhibitor Sic1 and for the G 1 to S cell cycle transition. These findings provide a further link between VHL and the cellular ubiquitination machinery.


Related Papers

No related papers found

Powered by citation graph analysis